What Determines Cross‐Country Access to Antiretroviral Treatment?
- 13 April 2006
- journal article
- Published by Wiley in Development Policy Review
- Vol. 24 (3) , 321-337
- https://doi.org/10.1111/j.1467-7679.2006.00327.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Scaling Up AIDS Treatment in Developing Countries: A Review of Current and Future ArgumentsDevelopment Policy Review, 2005
- The impact of reduced drug prices on the cost-effectiveness of HAART in South AfricaAfrican Journal of AIDS Research, 2005
- Integrating HIV Prevention and Treatment: From Slogans to ImpactPLoS Medicine, 2005
- Scaling up access to antiretroviral treatment in southern Africa: who will do the job?The Lancet, 2004
- How will HIV/AIDS transform African governance?African Affairs, 2003
- HIV prevention before HAART in sub-Saharan AfricaThe Lancet, 2002
- Poverty and Health in Southern Africa:Evidence from the Demographic and Health Survey (DHS)South African Journal of Economics, 2002
- Community-based approaches to HIV treatment in resource-poor settingsThe Lancet, 2001
- Correlation of Human Immunodeficiency Virus Type 1 RNA Levels in Blood and the Female Genital TractThe Journal of Infectious Diseases, 1999
- A Longitudinal Study of Human Immunodeficiency Virus Transmission by Heterosexual PartnersNew England Journal of Medicine, 1994